Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Endo International
Endo International
Here's how Raleigh's BioDelivery plans to spend $50 million
Bizjournals.com
Mon, 10/26/15 - 09:46 pm
BioDelivery Sciences
R&D
Belbuca
Endo International
8 BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sat, 10/24/15 - 02:28 pm
AbbVie
Gilead Sciences
Endo International
Synta Pharmaceuticals
Valeant Pharmaceuticals
Relypsa
Repros Therapeutics
Ocular Therapeutix
Drugmakers Are Distancing Themselves From Valeant
Bloomberg
Fri, 10/23/15 - 05:10 pm
Valeant Pharmaceuticals
Endo International
Allergan
Horizon Pharma
Mallinckrodt
Endo clarifies use of specialty pharmacies amid 'market speculation'
Bizjournals.com
Thu, 10/22/15 - 09:51 am
Endo International
specialty pharmacies
Valeant Pharmaceuticals
No, Endo Isn’t Valeant
Barron's
Tue, 09/29/15 - 10:10 pm
Endo International
Valeant Pharmaceuticals
M&A
Endo completes $8B acquisition of Par
Bizjournals.com
Tue, 09/29/15 - 08:55 am
Endo International
M&A
Par Pharmaceutical
Drug launch in Japan to trigger $20M payment to Endo
Bizjournals.com
Mon, 08/31/15 - 05:32 pm
Japan
drug launches
Endo International
Xiaflex
Endo Wins Order Blocking Generic of Opana ER Until 2023
Bloomberg
Sat, 08/15/15 - 10:54 am
Endo International
generics
Opana ER
Actavis
painkillers
Endo reports 2Q loss
Yahoo/AP
Mon, 08/10/15 - 08:01 am
Endo International
Endo reveals $9.275 bln loan package for Par buy
Reuters
Thu, 05/21/15 - 02:12 pm
Endo International
Par Pharmaceutical
M&A
7 Biotech Stocks Moving Off The UBS Healthcare Conference
Yahoo/Benzinga
Tue, 05/19/15 - 04:57 pm
biotech
UBS
AcelRx
Affirmed NV
Atara
Cerulean Pharma
Endo International
Esperion Therapeutics
Immune Design
Endo Vaults Into Top 5 Among Generic-Drug Firms
Yahoo/Investors.com
Mon, 05/18/15 - 10:00 pm
generics
Endo International
Par Pharmaceutical
M&A
Endo to buy Par Pharma for about $8 billion
Marketwatch
Mon, 05/18/15 - 09:00 am
Endo International
Par Pharmaceutical
M&A
Vivus' Stendra To Get A Re-Launch
Seeking Alpha
Tue, 05/12/15 - 04:21 pm
Vivus
Stendra
Endo International
drug launches
erectile dysfunction
Endo misses Street 1Q forecasts
Yahoo/AP
Tue, 05/12/15 - 09:29 am
Endo International
earnings
Pages
« first
‹ previous
1
2
3
4